• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性胆汁性胆管炎无症状期发病机制的新认识。

New insights into the pathogenesis of primary biliary cholangitis asymptomatic stage.

机构信息

Department of Propaedeutics of Internal Diseases and Gastroenterology, A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow 127473, Russia.

出版信息

World J Gastroenterol. 2023 Oct 7;29(37):5292-5304. doi: 10.3748/wjg.v29.i37.5292.

DOI:10.3748/wjg.v29.i37.5292
PMID:37899787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10600802/
Abstract

Primary biliary cholangitis (PBC) is a chronic cholestatic progressive liver disease and one of the most important progressive cholangiopathies in adults. Damage to cholangiocytes triggers the development of intrahepatic cholestasis, which progresses to cirrhosis in the terminal stage of the disease. Accumulating data indicate that damage to biliary epithelial cells [(BECs), cholangiocytes] is most likely associated with the intracellular accumulation of bile acids, which have potent detergent properties and damaging effects on cell membranes. The mechanisms underlying uncontrolled bile acid intake into BECs in PBC are associated with pH change in the bile duct lumen, which is controlled by the bicarbonate (HCO) buffer system "biliary HCO umbrella". The impaired production and entry of HCO from BECs into the bile duct lumen is due to epigenetic changes in expression of the X-linked microRNA 506. Based on the growing body of knowledge on the molecular mechanisms of cholangiocyte damage in patients with PBC, we propose a hypothesis explaining the pathogenesis of the first morphologic (ductulopenia), immunologic (antimitochondrial autoantibodies) and clinical (weakness, malaise, rapid fatigue) signs of the disease in the asymptomatic stage. This review focuses on the consideration of these mechanisms.

摘要

原发性胆汁性胆管炎(PBC)是一种慢性胆汁淤积性进行性肝脏疾病,也是成人最重要的进行性胆管疾病之一。胆管细胞损伤会引发肝内胆汁淤积,在疾病终末期进展为肝硬化。越来越多的数据表明,胆管上皮细胞(BECs,胆管细胞)的损伤最可能与胆汁酸在细胞内的积累有关,胆汁酸具有很强的去污特性,对细胞膜有损伤作用。PBC 中胆汁酸不受控制地摄入 BECs 的机制与胆管腔内 pH 值的变化有关,该变化由碳酸氢盐(HCO)缓冲系统“胆管 HCO 保护伞”控制。BECs 中 HCO 的产生和进入胆管腔受损是由于 X 连锁微小 RNA 506 的表达发生表观遗传改变所致。基于对 PBC 患者胆管细胞损伤的分子机制的不断增加的认识,我们提出了一个假说,解释了疾病无症状阶段的第一个形态学(胆管减少症)、免疫学(抗线粒体自身抗体)和临床(乏力、不适、快速疲劳)体征的发病机制。本综述重点考虑了这些机制。

相似文献

1
New insights into the pathogenesis of primary biliary cholangitis asymptomatic stage.原发性胆汁性胆管炎无症状期发病机制的新认识。
World J Gastroenterol. 2023 Oct 7;29(37):5292-5304. doi: 10.3748/wjg.v29.i37.5292.
2
MicroRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation.微小 RNA-506 促进胆管细胞原发性胆汁性胆管炎样特征和免疫激活。
Hepatology. 2018 Apr;67(4):1420-1440. doi: 10.1002/hep.29533. Epub 2018 Feb 21.
3
Secretin alleviates biliary and liver injury during late-stage primary biliary cholangitis via restoration of secretory processes.促胰液素通过恢复分泌过程减轻晚期原发性胆汁性胆管炎期间的胆道和肝脏损伤。
J Hepatol. 2023 Jan;78(1):99-113. doi: 10.1016/j.jhep.2022.07.034. Epub 2022 Aug 18.
4
Role of Bile Acids and the Biliary HCO Umbrella in the Pathogenesis of Primary Biliary Cholangitis.胆汁酸和胆盐HCO3-伞在原发性胆汁性胆管炎发病机制中的作用。
Clin Liver Dis. 2018 Aug;22(3):457-479. doi: 10.1016/j.cld.2018.03.013. Epub 2018 May 19.
5
Immunologic Responses and the Pathophysiology of Primary Biliary Cholangitis.原发性胆汁性胆管炎的免疫反应和病理生理学。
Clin Liver Dis. 2022 Nov;26(4):583-611. doi: 10.1016/j.cld.2022.06.003. Epub 2022 Sep 14.
6
Bile Acids and Deregulated Cholangiocyte Autophagy in Primary Biliary Cholangitis.原发性胆汁性胆管炎中的胆汁酸与胆管细胞自噬失调
Dig Dis. 2017;35(3):210-216. doi: 10.1159/000450913. Epub 2017 Mar 1.
7
Role of the bicarbonate-responsive soluble adenylyl cyclase in cholangiocyte apoptosis in primary biliary cholangitis; a new hypothesis.碳酸氢盐反应性可溶性腺苷酸环化酶在原发性胆汁性胆管炎胆管细胞凋亡中的作用;一个新假说。
Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1232-1239. doi: 10.1016/j.bbadis.2017.09.022. Epub 2017 Sep 28.
8
An impaired biliary bicarbonate umbrella may be involved in dysregulated autophagy in primary biliary cholangitis.一个受损的胆盐碳酸氢盐伞可能参与原发性胆汁性胆管炎中失调的自噬。
Lab Invest. 2018 Jun;98(6):745-754. doi: 10.1038/s41374-018-0045-4. Epub 2018 Mar 14.
9
Primary biliary cholangitis: primary autoimmune disease or primary secretory defect.原发性胆汁性胆管炎:原发性自身免疫性疾病还是原发性分泌缺陷。
Expert Rev Gastroenterol Hepatol. 2023 Jul-Dec;17(9):863-870. doi: 10.1080/17474124.2023.2242771. Epub 2023 Aug 3.
10
Primary biliary cholangitis: pathogenic mechanisms.原发性胆汁性胆管炎:发病机制。
Curr Opin Gastroenterol. 2021 Mar 1;37(2):91-98. doi: 10.1097/MOG.0000000000000703.

引用本文的文献

1
Primary biliary cholangitis: A historical perspective from xanthomatous lesions to modern molecular biology.原发性胆汁性胆管炎:从黄色瘤病变到现代分子生物学的历史视角
World J Gastrointest Pathophysiol. 2025 Jun 22;16(2):107347. doi: 10.4291/wjgp.v16.i2.107347.
2
Bile acid therapy for primary biliary cholangitis: Pathogenetic validation.原发性胆汁性胆管炎的胆汁酸疗法:发病机制验证。
World J Exp Med. 2025 Mar 20;15(1):101771. doi: 10.5493/wjem.v15.i1.101771.
3
Advances, challenges and future applications of liver organoids in experimental regenerative medicine.肝脏类器官在实验性再生医学中的进展、挑战及未来应用
Front Med (Lausanne). 2025 Jan 24;11:1521851. doi: 10.3389/fmed.2024.1521851. eCollection 2024.
4
Itching for Answers: A Comprehensive Review of Cholestatic Pruritus Treatments.《瘙痒求解:胆汁淤积性瘙痒治疗的全面综述》
Biomolecules. 2024 Sep 28;14(10):1227. doi: 10.3390/biom14101227.
5
Editor-in-Chief articles of choice and comments at the year-end of 2023.2023 年年末主编精选文章及评论。
World J Gastroenterol. 2024 Jan 7;30(1):1-8. doi: 10.3748/wjg.v30.i1.1.

本文引用的文献

1
Novel allele associations with susceptibility, staging, symptomatic state, autoimmune hepatitis and hepatocellular carcinoma events for primary biliary cholangitis in the Japanese population.在日本人群中,新型等位基因与原发性胆汁性胆管炎的易感性、分期、症状状态、自身免疫性肝炎和肝细胞癌事件相关。
Front Immunol. 2023 May 31;14:1151502. doi: 10.3389/fimmu.2023.1151502. eCollection 2023.
2
Quality of life in Dutch patients with primary biliary cholangitis: Discrepancies between patients' perspectives and objective disease parameters.荷兰原发性胆汁性胆管炎患者的生活质量:患者观点与客观疾病参数之间的差异。
Hepatol Res. 2023 May;53(5):401-408. doi: 10.1111/hepr.13880. Epub 2023 Jan 24.
3
Cellular and transcriptional heterogeneity in the intrahepatic biliary epithelium.肝内胆管上皮细胞及转录异质性
Gastro Hep Adv. 2023;2(1):108-120. doi: 10.1016/j.gastha.2022.07.015. Epub 2022 Aug 5.
4
Immunologic Responses and the Pathophysiology of Primary Biliary Cholangitis.原发性胆汁性胆管炎的免疫反应和病理生理学。
Clin Liver Dis. 2022 Nov;26(4):583-611. doi: 10.1016/j.cld.2022.06.003. Epub 2022 Sep 14.
5
Differential immune response to xenobiotic-modified self-molecule in simple and connective tissue disease-associated primary biliary cholangitis.原发性胆汁性胆管炎中单纯性和结缔组织病相关患者对外源性修饰自身分子的免疫应答差异。
Liver Int. 2022 Oct;42(10):2204-2215. doi: 10.1111/liv.15360. Epub 2022 Jul 25.
6
Antimitochondrial Antibodies: from Bench to Bedside.抗线粒体抗体:从实验室到临床
Clin Rev Allergy Immunol. 2022 Oct;63(2):166-177. doi: 10.1007/s12016-021-08904-y. Epub 2021 Sep 29.
7
Seladelpar improved measures of pruritus, sleep, and fatigue and decreased serum bile acids in patients with primary biliary cholangitis.Seladelpar 改善了原发性胆汁性胆管炎患者的瘙痒、睡眠和疲劳等症状,并降低了血清胆汁酸水平。
Liver Int. 2022 Jan;42(1):112-123. doi: 10.1111/liv.15039. Epub 2021 Aug 26.
8
Primary biliary cholangitis: pathogenic mechanisms.原发性胆汁性胆管炎:发病机制。
Curr Opin Gastroenterol. 2021 Mar 1;37(2):91-98. doi: 10.1097/MOG.0000000000000703.
9
Clinical Updates in Primary Biliary Cholangitis: Trends, Epidemiology, Diagnostics, and New Therapeutic Approaches.原发性胆汁性胆管炎的临床进展:趋势、流行病学、诊断及新治疗方法
J Clin Transl Hepatol. 2020 Mar 28;8(1):49-60. doi: 10.14218/JCTH.2019.00049. Epub 2020 Jan 29.
10
Inositol 1,4,5-trisphosphate receptor in the liver: Expression and function.肝脏中的肌醇 1,4,5-三磷酸受体:表达与功能。
World J Gastroenterol. 2019 Nov 28;25(44):6483-6494. doi: 10.3748/wjg.v25.i44.6483.